List of insiders holdings for CONTRAFECT CORP COM PAR $0.000:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Shanghai Fosun Pharmaceutical (Group) Co. Ltd. 10% Owner | 2018-12-06 16:51:27 | 0 7,900,000 | 7,900,000 | Form 4 |
| ERNEST W MOODY REVOCABLE TRUST 10% Owner | 2015-10-22 15:09:11 | 1,856,681 0 | 1,856,681 | Form 4 |
| Fosun Industrial Co. Ltd 10% Owner | 2021-01-26 06:06:25 | 1,170,385 0 | 1,170,385 | Form 13G |
| Nowinski Robert C. 10% Owner | 2014-07-28 21:41:47 | 1,146,098 0 | 1,146,098 | Form 3 |
| Pomerantz Roger Chief Executive Officer | 2022-02-17 18:18:58 | 500,000 0 | 500,000 | Form 4 |
| Ricciardi Lisa Chief Operating Officer | 2017-11-08 16:21:21 | 250,000 0 | 250,000 | Form 4 |
| Muntner Joshua B SVP Business Development | 2018-02-07 16:50:07 | 200,000 0 | 200,000 | Form 4 |
| GREGORY JULIA P CEO | 2016-02-17 16:38:40 | 200,000 0 | 200,000 | Form 4 |
| Cassino Cara M Chief Medical Officer | 2022-02-17 18:09:19 | 160,000 0 | 160,000 | Form 4 |
| Bogdanos Natalie General Counsel | 2022-02-17 18:03:46 | 125,000 0 | 125,000 | Form 4 |
| Wittekind Michael G. Chief Scientific Officer | 2016-02-17 16:33:42 | 80,000 0 | 80,000 | Form 4 |
| OTTO MICHAEL J. Director | 2022-05-18 19:58:49 | 42,000 0 | 42,000 | Form 4 |
| Sucoff Cary Director | 2022-05-18 20:03:32 | 42,000 0 | 42,000 | Form 4 |
| Low David N. Director | 2022-05-18 18:10:23 | 42,000 0 | 42,000 | Form 4 |
| Barlow Jane F Director | 2022-05-18 20:12:43 | 42,000 0 | 42,000 | Form 4 |
| Aklog Lishan Director | 2022-05-18 17:53:07 | 42,000 0 | 42,000 | Form 4 |
| BARER SOL J Director | 2022-05-18 17:59:08 | 42,000 0 | 42,000 | Form 4 |
| GILMAN STEVEN C Director | 2022-05-18 18:04:26 | 42,000 0 | 42,000 | Form 4 |
| Couto Daniel SVP Manufacturing & Facilities | 2016-02-17 16:37:12 | 40,000 0 | 40,000 | Form 4 |
| Dong Nancy VP Finance & Administration | 2020-02-21 17:17:39 | 40,000 0 | 40,000 | Form 4 |
| Tian Lawrence Yuan Director | 2015-05-07 16:08:17 | 30,000 8,571 | 38,571 | Form 3/A |
| Messinger Michael Chief Financial Officer | 2023-02-16 20:09:36 | 25,000 0 | 25,000 | Form 4 |
| Huang David B. Chief Medical Officer | 2014-10-08 14:16:59 | 23,901 0 | 23,901 | Form 4 |
| BLECH ISAAC Director | 2019-05-29 16:33:36 | 22,500 0 | 22,500 | Form 4 |
| Kappel Barry J. SVP Business Development | 2015-02-18 18:18:52 | 17,032 0 | 17,032 | Form 5 |
| SCHEINBERG DAVID A Director | 2015-05-06 18:30:16 | 15,000 0 | 15,000 | Form 4 |
| Zan Shengda Director | 2015-02-10 17:02:51 | 5,000 0 | 5,000 | Form 4 |